-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Apotex Health, Raises Price Target to C$46

Benzinga·11/13/2026 15:34:23
Listen to the news
RBC Capital analyst Douglas Miehm maintains Apotex Health (TSX:APTX) with a Outperform and raises the price target from C$43 to C$46.